Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Biochemical and Biophysical Research Communications
|
May 8, 2022
Memory-like response in platelet attenuates platelet hyperactivation in arterial thrombosis
Qiushi Sun, Hai Niu, Chengyu Wan, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
July 6, 2022
Berberine-mediated REDD1 down-regulation ameliorates senescence of retinal pigment epithelium by interrupting the ROS-DDR positive feedback loop
Qingqiu Chen, Guang Xin, Shiyi Li, et al.
Free Radical Research
|
January 2, 2023
Deoxyarbutin attenuates severe acute pancreatitis via the HtrA2/PGC-1α pathway
Yangying Li, Yuda Zhu, Shiyi Li, et al.
Analytical Chemistry
|
September 4, 2025
Near Infrared-Responsive Xanthene Probes for Dual-Mode Cancer Treatment and Bioimaging
Junfeng Zhang, Lingyu Jin, Bin Xiao, et al.
Molecular Genetics and Metabolism
|
February 25, 2026
Age-dependent reference intervals for cerebrospinal fluid and urine biomarkers of mucopolysaccharidoses
Candice B Herber, Shaohua Xiao, Deborah S Gho, et al.
Annals of Clinical and Translational Neurology
|
June 10, 2020
Longitudinal biomarkers in amyotrophic lateral sclerosis
Fen Huang, Yuda Zhu, Jennifer Hsiao-Nakamoto, et al.
International Journal of Molecular Sciences
|
July 26, 2020
Characterization of Fluid Biomarkers Reveals Lysosome Dysfunction and Neurodegeneration in Neuronopathic MPS II Patients
Akhil Bhalla, Ritesh Ravi, Meng Fang, et al.
JCI Insight
|
October 8, 2021
Iduronate-2-sulfatase transport vehicle rescues behavioral and skeletal phenotypes in a mouse model of Hunter syndrome
Annie Arguello, René Meisner, Elliot R Thomsen, et al.
Clinical and Translational Science
|
June 1, 2022
Safety, pharmacokinetics and target engagement of novel RIPK1 inhibitor SAR443060 (DNL747) for neurodegenerative disorders: Randomized, placebo-controlled, double-blind phase I/Ib studies in healthy subjects and patients
Maurits F J M Vissers, Jules A A C Heuberger, Geert Jan Groeneveld, et al.
Science Translational Medicine
|
June 8, 2022
Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's disease
Danna Jennings, Sarah Huntwork-Rodriguez, Anastasia G Henry, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Biochemical and Biophysical Research Communications
|
May 8, 2022
Memory-like response in platelet attenuates platelet hyperactivation in arterial thrombosis
Qiushi Sun, Hai Niu, Chengyu Wan, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
July 6, 2022
Berberine-mediated REDD1 down-regulation ameliorates senescence of retinal pigment epithelium by interrupting the ROS-DDR positive feedback loop
Qingqiu Chen, Guang Xin, Shiyi Li, et al.
Free Radical Research
|
January 2, 2023
Deoxyarbutin attenuates severe acute pancreatitis via the HtrA2/PGC-1α pathway
Yangying Li, Yuda Zhu, Shiyi Li, et al.
Analytical Chemistry
|
September 4, 2025
Near Infrared-Responsive Xanthene Probes for Dual-Mode Cancer Treatment and Bioimaging
Junfeng Zhang, Lingyu Jin, Bin Xiao, et al.
Molecular Genetics and Metabolism
|
February 25, 2026
Age-dependent reference intervals for cerebrospinal fluid and urine biomarkers of mucopolysaccharidoses
Candice B Herber, Shaohua Xiao, Deborah S Gho, et al.
Annals of Clinical and Translational Neurology
|
June 10, 2020
Longitudinal biomarkers in amyotrophic lateral sclerosis
Fen Huang, Yuda Zhu, Jennifer Hsiao-Nakamoto, et al.
International Journal of Molecular Sciences
|
July 26, 2020
Characterization of Fluid Biomarkers Reveals Lysosome Dysfunction and Neurodegeneration in Neuronopathic MPS II Patients
Akhil Bhalla, Ritesh Ravi, Meng Fang, et al.
JCI Insight
|
October 8, 2021
Iduronate-2-sulfatase transport vehicle rescues behavioral and skeletal phenotypes in a mouse model of Hunter syndrome
Annie Arguello, René Meisner, Elliot R Thomsen, et al.
Clinical and Translational Science
|
June 1, 2022
Safety, pharmacokinetics and target engagement of novel RIPK1 inhibitor SAR443060 (DNL747) for neurodegenerative disorders: Randomized, placebo-controlled, double-blind phase I/Ib studies in healthy subjects and patients
Maurits F J M Vissers, Jules A A C Heuberger, Geert Jan Groeneveld, et al.
Science Translational Medicine
|
June 8, 2022
Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's disease
Danna Jennings, Sarah Huntwork-Rodriguez, Anastasia G Henry, et al.
Page
of 5